October 8-11
Gaylord National, Maryland
(Washington, DC, area)

Register Now for CAP17

The Right Knowledge.
The Right Diagnosis.

Industry and CAP Workshops

The CAP does not endorse the content of the industry workshops, individual presenters, or sponsoring companies.

Sunday, October 8
11:45 AM–1:15 PM

IWSL700 Industry Lunch Workshop – Discovering Testing for PDL-1 and EGFR and What Treatment Options Are for Patients That Have Progressed After EGFR-TKI Therapy
CME/CE NOT APPLICABLE


Sunday, October 8
11:45 AM–1:15 PM

IWSL701 Industry Lunch Workshop – An Approach to Common Issues Facing the Practicing Pathologist Who Encounters GI Specimens
CME/CE NOT APPLICABLE

This session will focus on two of the issues most frequently encountered by pathologists evaluating GI pathology specimens: 1) Barrett’s esophagus and Barrett’s-related dysplasia and 2) the pathologic evaluation of colorectal carcinoma, including the use of an algorithmic approach to molecular testing of colorectal carcinoma specimens.

Presenters

John Goldblum, MD
Thomas Plesec, MD


Sunday, October 8
11:45 AM–1:15 PM

IWSL702 Industry Lunch Workshop – Making Certain We Get the Right Diagnosis for Our Patients: p16 on cervical biopsies—Results From the CINtec Histology CERTAIN Study
CME/CE NOT APPLICABLE

The landmark CERTAIN (CERvical Tissue AdjunctIve aNalysis) study, which supported the CINtec® Histology 510(k) FDA clearance in the US, is presented in this workshop. The CERTAIN study is one of the largest immunohistochemistry clinical studies conducted to date with more than 38,500 slide interpretations by 70 participating pathologists. Based on the p16 biomarker, the CINtec Histology test, used along with H&E, increased the diagnostic agreement among community pathologists and the expert panel for high-grade precancer in cervical biopsies. For pathologists this means that you can be certain in your diagnosis so that your patients are likely to receive the appropriate follow-up care.

Presenters

Teresa M. Darragh, MD, FCAP
Professor of Clinical Pathology
UCSF Mt. Zion Medical Center


Monday, October 9
7:30–8:45 AM

IWMB705 Industry Breakfast Workshop – Biomarkers in Immuno-Oncology
CME/CE NOT APPLICABLE

This seminar will examine the status of cancer immunotherapies and the use of predictive biomarkers to guide therapy.

Presenters

Steve Anderson, PhD, Chief Scientific Officer, Covance/LabCorp
Taylor Jensen, PhD, Director, Research and Development, Sequenom/LabCorp


Monday, October 9
7:30–8:45 AM

IWMB706 Industry Breakfast Workshop – Molecular Testing and the New AJCC Guidelines for Breast Cancer: What Does This Mean for My Practice?
CME/CE NOT APPLICABLE


Monday, October 9
7:30–8:45 AM

IWMB707 Industry Lunch Workshop – SOLAR (Science of Lymphoma and Associated Receptors)
CME/CE NOT APPLICABLE

A scientific forum addressing principles of lymphomagenesis, approaches to systematic diagnosis, and rational therapeutic targeting to improve patient management.

Program Overview

Seattle Genetics, an expert in lymphoma, is proud to provide a different type of disease education program. Delivered by a lymphoma expert, SOLAR illustrates fundamental principles in the biology of lymphoma, a systematic approach to differential diagnosis in a case-based format, and rationale for potential therapeutic targets. The SOLAR content was developed in consultation with national lymphoma and pathology experts from academic centers.

Target Audience

This scientific forum is intended for medical and hematological oncologists, pathologists, oncology/hematology fellows, and other physicians involved in the spectrum of cancer care. This content focuses on fundamental principles in lymphoma, including how lymphoma receptor biology can improve disease classification, diagnosis, and treatment.

Topics covered in this workshop include:

  • Lymphoma heterogeneity
  • Lymphocyte development and surface receptor expression
  • Immunophenotyping of lymphomas
  • Case study: lymphoma differential diagnosis
  • Rational targeting strategies for lymphoma treatment
  • Importance of timely clinical trial enrollment

The SOLAR scientific program focuses on disease education and is not intended to promote any cancer agent approved by the FDA or agents under investigation.

The Science of Lymphoma and Associated Receptors (SOLAR) slide presentation, provided by Seattle Genetics, Inc., is not an independent educational program and no CME credits will be provided.


Monday, October 9
7:30–8:45 AM

IWML708 Industry Breakfast Workshop – What’s New in Tissue-Based HPV Testing?
CME/CE NOT APPLICABLE

Presenter

Dr. Rob Monroe, Chief Medical Officer of Advanced Cell Diagnostics, a biotechne brand


Monday, October 9
11:45 AM–1:15 PM

IWML710 Industry Lunch Workshop – Pathology Reimbursement Models of the Future
CME/CE NOT APPLICABLE

Profitability, efficiency, and compliance: These are the goals of every practice and laboratory, but today’s complex health care market does not make them easy to reach. Payors and policymakers are struggling with a wide variety of cost control initiatives while increasing the demand for providers to document higher and higher quality outcomes. Therefore, pathology groups will need to identify effective and efficient strategies for maintaining a competitive advantage and financial footing in the market.

In this discussion, Rick Cooper, Esq., McDonald Hopkins, LLC, and Linda Liston, CPC, director, Managed Care Services, McKesson Revenue Management Solutions, will focus on current issues and initiatives, such as:

  • Evaluating the current payor issues reshaping the industry
  • Analyzing productivity and implementing strategies for future success
  • Avoiding payor disputes, audits, and recoupment actions
  • Developing strategic partnership through mergers, acquisitios, and alliances
  • Increasing perceived value to hospitals, physicians, and patients

Join us to learn how your pathology group can prosper and build a healthier bottom line.


Monday, October 9
11:45 AM–1:15 PM

IWML711 Industry Lunch Workshop – Exploring Immuno-Oncology Biomarkers: PD-L1 and Beyond
CME/CE NOT APPLICABLE


Tuesday, October 10
7:30–8:45 AM

CWTB740 CAP Breakfast Workshop – Justifying the Introduction of Emerging Technologies Into a Pathology Department: How to Develop a Business Plan
CME/CE NOT APPLICABLE

While the discipline of surgical pathology remains the traditional “gold standard” for clinical tissue diagnoses, technological advances in biomedical optics and quantitative image analysis are rapidly emerging as complimentary diagnostic and prognostic tools for pathologists. As with all new medical technologies, investment justifications often need to be considered before formal reimbursement codes are established. Using the emerging technology of ex-vivo microscopy (EVM) as an example, this presentation will consider how to build a business plan to justify investing in such technology, in terms of the impact on workflow, productivity, changes in clinical services, new capital purchases, and trainee education.


Tuesday, October 10
7:30–8:45 AM

CWTB741 CAP Breakfast Workshop – A Laboratory Information System Implementation of Epic Proportions: The Ongoing Saga of One Academic Health System
CME/CE NOT APPLICABLE

One of the largest installations of Epic’s software for anatomic and clinical pathology laboratories was completed at Duke University Medical Center in October of 2014. This breakfast workshop will provide an account of the work involved in team building, go-live planning, post-go-live challenges, and operational governance. The workshop has been updated this year to include a more in-depth look at the Beaker data model, with associated reporting and analytic tools available for data dissection. Presenters will cover software implementation and informatics principles; and, in general, the information will be applicable regardless of the information system selected by a health system. A significant amount of time will be devoted to a question and answer session to address specifics, so please come prepared with your questions to contribute to a lively open discussion.

Presenter

Raj Dash, MD, FCAP


Tuesday, October 10
6:00–9:00 PM

IWTD712 Industry Dinner Workshop – Philips Live! – Digital Transformation in Pathology
CME/CE NOT APPLICABLE

Digital pathology for primary diagnostics is now available. How will it help you improve your clinical workflow and collaboration across sites? Visit our Philips Live! – CAP17 Industry Dinner Workshop and experience digital pathology for yourself. Learn from experts how it can help you in your daily work and how to start your digital transition journey.

  • Dr. Stephen Hewitt, Chief Tissue Research Program and Aapplied Molecular Pathology laboratory of the National Cancer Institute, will share his view on digital pathology.
  • Get hands-on with the Image Management System, Viewer and Ultra-Fast Scanner of the Philips IntelliSite Pathology Solution.
  • See the benefits of a digital workflow with our digital pathology lab VR Experience.
  • Discover the steps towards 100% digital workflow.
  • Learn how future use of computational pathology will amplify your expertise.